endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Financing channel feed

Stephen Squin­to's JPM life sci­ences team is rais­ing a new fund for lat­er-stage com­pa­nies

6 months ago
Startups

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

6 months ago
Cell/Gene Tx

Evom­mune rais­es $115M for I&I pipeline and pre­pares for Phase 2 re­sults

6 months ago
Startups

Blue Earth Ther­a­peu­tics snags $76M for both al­pha and be­ta ra­dio­ther­a­pies

6 months ago
Startups

A start­up backed by No­bel win­ner David Bak­er takes an AI twist on an­ti­bod­ies

6 months ago
Startups
AI

Ax­o­nis snags $115M to test oral drugs for epilep­sy and neu­ro­path­ic pain

7 months ago
Startups

Pathos AI nabs $62M Se­ries C as it hunts for more Phase 1 drugs with AI

7 months ago
AI

Synaf­fix, in­dus­try's ADC part­ner of choice, spins out a start­up pipeline

7 months ago
Startups

Septer­na bags $288M up­sized IPO for GPCR drugs

7 months ago
Startups

Sanofi backs fi­bro­sis biotech Agomab as it rais­es $89M Se­ries D

7 months ago
Startups
Pharma

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

7 months ago
AI

Ra­dio­phar­ma star­tups stay hot as Al­pha-9 bags $175M Se­ries C

7 months ago
Startups

Life sci­ences in­vestor Di­men­sion seeks to raise $500M sec­ond fund

7 months ago
Startups

Hous­ton start­up March Bio­sciences rais­es $28M to get CAR-T in­to Phase 2

7 months ago
Startups
Cell/Gene Tx

Be Bio rais­es $82M to fund work on B cell ther­a­py in he­mo­phil­ia B

7 months ago
Startups
R&D

Aven­Cell gets $112M to build switch­able CAR-T ther­a­pies for ‘the last fron­tier’ of blood can­cers

7 months ago
Cell/Gene Tx

Q3 biotech roundup: The 2024 turn­around sput­ters in­to a crit­i­cal Q4 fi­nale

7 months ago
Startups
Bioregnum

Septer­na out­lines $157M IPO af­ter en­ter­ing the clin­ic with GPCR pipeline

7 months ago
Startups

For­mer Karuna crew quick­ly as­sem­bles $225M for next neu­ro bet at Sea­port

7 months ago
Startups

Shang­hai biotech’s VEGF bis­pe­cif­ic en­ters Phase 1 tri­al in Chi­na

7 months ago
R&D

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

7 months ago
Startups

Ex­clu­sive: Ter­ray rais­es $120M for its AI ways of de­sign­ing mol­e­cules

7 months ago
AI

Life sci­ences in­vestor KdT Ven­tures rais­es $100M fund to back new star­tups

7 months ago
Startups

Tol­er­ance Bio emerges from stealth with $17.2M to ad­vance ther­a­pies de­vel­oped from the thy­mus

7 months ago
Startups
First page Previous page 567891011 Next page Last page
A service from the Financial Times